How Barie Summarises the Latest WHO Guidelines on Antimicrobial Resistance and Compares Them with the CDC’s Approach

Medical Research  ·  Deep Research  ·  WHO · CDC Live Sources  ·  Updated April 2026

Barie pulls the actual WHO and CDC guideline documents from their official live sources. It builds a structured comparison across key recommendations, approach differences, and implementation timelines — with a source link to every guideline referenced. Not a training-data summary of what these documents said at some undated point in the past.

Why AMR guidelines from training data are unreliable

Antimicrobial resistance is one of the fastest-evolving areas in global public health. The WHO updates its AMR action plan, essential medicines list, and antibiotic prioritisation criteria on a rolling basis. The CDC revises its treatment recommendations as new resistance patterns emerge and as new data on antibiotic efficacy accumulates. A comparison drawn from training data describes the guidance landscape at an unknown historical point and may misrepresent documents that have since been updated, superseded, or significantly amended.

For a clinician, public health officer, researcher, or policy analyst, the difference between the current WHO guidance and the version from two years ago can be material. The 2024 WHO Bacterial Priority Pathogens List updated the classification of several organisms, revising which pathogens are in the Critical versus High priority tier. The CDC’s updated stewardship framework from 2023 introduced revised core elements for antibiotic stewardship programmes that differ from the earlier version. Neither of these changes can be found in training data that predates their publication.

Barie Deep Research retrieves the actual documents: Barie queries WHO.int and CDC.gov directly, retrieving the current versions of the relevant guidelines, action plans, and priority pathogen lists. Barie Web Research then checks for recent supplementary guidance, technical notes, or Dear Colleague letters that update or clarify the base documents. The comparison is built from what the two organisations are actually recommending today.

Your prompt

Task prompt: “Summarise the latest WHO guidelines on antimicrobial resistance and compare with the CDC’s approach.”

One sentence. Barie fires two parallel retrieval threads from the official WHO and CDC sources, extracts the current guideline positions across four comparison dimensions, applies a structured analysis framework, and delivers the comparison with a source link to the primary document for every claim. Here is exactly how the workflow runs.

Step 1: WHO and CDC sources retrieved simultaneously from official live pages

TWO PARALLEL DEEP RESEARCH THREADS

Both threads fire at the same time. The WHO thread retrieves the current WHO AMR Global Action Plan, the 2024 Bacterial Priority Pathogens List, the WHO Essential Medicines List antibiotic section, and the GLASS (Global Antimicrobial Resistance and Use Surveillance System) latest annual report. The CDC thread retrieves the current CDC Antibiotic Resistance Threats report, the Core Elements of Hospital Antibiotic Stewardship Programs guidance, the CDC treatment guidelines for specific resistant organisms, and any Dear Colleague communications issued in the current year.

WHO Sources — Live retrieval

• WHO AMR Global Action Plan 2015–2025 — current status update
• WHO Bacterial Priority Pathogens List 2024 — updated classification
• WHO Essential Medicines List — antibiotic access and watch categories
• GLASS Annual Report 2024 — global resistance surveillance data
• WHO AWaRe (Access, Watch, Reserve) — antibiotic categorisation

CDC Sources — Live retrieval

• CDC Antibiotic Resistance Threats in the United States — latest edition
• Core Elements of Hospital Antibiotic Stewardship Programs — 2023 revision
• CDC treatment guidance for priority resistant organisms — 
• National Action Plan for Combating Antibiotic-Resistant Bacteria — 
• CDC NHSN resistance surveillance — current reporting data

Web Research catches recent supplementary guidance: After the primary document retrieval, Barie Web Research checks both organisations’ recent publications pages for technical notes, implementation guidance, and any updates issued in the weeks before the search that may clarify or amend the base documents. AMR guidance is updated frequently and web retrieval catches the amendments that postdate the indexed document versions.

Step 2: The structured comparison — four dimensions, both frameworks, every claim sourced

STRUCTURED COMPARISON

With both source sets assembled, Barie applies a four-dimension comparison framework. Each dimension reflects a practical question that a clinician, researcher, or public health policy analyst would need answered when working across the two guideline frameworks.

Dimension 1: Priority Pathogen Classification

WHO: 

The 2024 WHO Bacterial Priority Pathogens List classifies 15 bacteria into three tiers: Critical, High, and Medium. The Critical tier includes carbapenem-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriaceae, and ESBL-producing Enterobacteriaceae. The 2024 update revised the classification methodology to incorporate factors beyond resistance rates, including treatability and disease burden.

[Global scope — 15 pathogens]  Source: WHO BPPL 2024

CDC: 

The CDC AR Threats report classifies resistant bacteria into Urgent, Serious, and Concerning threat levels. The Urgent category includes CRE, CDIFF (C. difficile), drug-resistant Neisseria gonorrhoeae, and CRAB. The CDC classification prioritises US-specific resistance prevalence and healthcare burden data rather than a global scope.

[US-specific threat data]  Source: CDC AR Threats

Dimension 2: Antibiotic Categorisation and Access Framework

WHO: 

The WHO AWaRe (Access, Watch, Reserve) framework categorises all antibiotics into three groups. Access antibiotics are first-line treatments recommended for wide availability. Watch antibiotics have higher resistance potential and require monitoring. Reserve antibiotics are last-resort agents. WHO recommends that at least 60% of antibiotic consumption should come from the Access group. This framework is designed for global implementation across healthcare systems of varying resource levels.

[AWaRe: Access, Watch, Reserve]  Source: WHO AWaRe 2023

CDC: 

The CDC uses a stewardship-focused framework rather than a global categorisation system. Antibiotic prescribing is guided by the Core Elements of Antibiotic Stewardship, which emphasise facility-level policy rather than a universal drug classification. The CDC does align with AWaRe categories in its international guidance but uses different operational frameworks for domestic implementation within US healthcare settings.

[Different domestic framework]  Source: CDC Stewardship Core Elements

Dimension 3: Stewardship Programme Requirements

WHO: 

WHO guidance on AMR stewardship focuses on national action plan implementation and targets low and middle income countries where stewardship infrastructure is still being established. The WHO toolkit for national action plans provides a framework for countries to build surveillance, prescribing governance, and healthcare worker training. Implementation timelines are flexible by design to accommodate varying health system capacities.

[National plan focused · LMIC priority]  Source: WHO NAP Toolkit

CDC: 

The 2023 revised Core Elements define seven domains for hospital stewardship programmes: leadership commitment, accountability, pharmacy expertise, tracking and reporting, education, actions, and reporting. The revision added a new emphasis on equitable antibiotic prescribing and expanded core elements for outpatient settings. CMS now requires hospitals to have antibiotic stewardship programmes as a condition of participation.

[CMS compliance requirement since 2023]  Source: CDC Core Elements 2023

Dimension 4: Implementation Timeline and Progress Milestones

WHO: 

The WHO AMR Global Action Plan 2015–2025 is in its final phase. A review of progress was published in 2024 with a mixed assessment — surveillance coverage has improved significantly, but prescribing reductions and resistance trend targets are behind schedule. Planning for the post-2025 AMR framework is underway, with a new international agreement on AMR prevention and control being drafted under the IACG mandate.

[2015–2025 plan ending · post-2025 in development]  Source: WHO AMR Progress Review 2024

CDC: 

The US National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB) runs on a five-year cycle. The current 2020–2025 plan set targets for reducing CDI infections, outpatient antibiotic prescribing rates, and healthcare-associated infections by specified percentages. The CDC published progress data in 2024 showing that outpatient prescribing reductions have been achieved, though some hospital-acquired infection targets remain off-track.

[CARB 2020–2025 · mixed progress]  Source: CARB National Action Plan

Every comparison cell links to the primary document, not a secondary summary: The WHO AWaRe framework cell links to the current WHO AWaRe categorisation document on WHO.int. The CDC Core Elements cell links to the 2023 revised guidance on CDC.gov. The comparison is not built from a third-party summary of what these documents say. It is built from the documents themselves, retrieved at query time.

Step 3: The comparison delivered to your research and policy tools

EXPORT AND DISTRIBUTION

The full comparison exports to Notion as a structured document with all four dimensions, source links, and a linked bibliography pointing to every WHO and CDC document retrieved. A formatted Word document version is available for inclusion in a policy brief, grant application, or clinical training material. A digest of the key differences goes to Slack for team awareness before the next policy or clinical review meeting.

Export flow: Notion → Google Docs → Word (.docx) → Slack

Reconfigurable as a monitoring workflow: Both the WHO and CDC update their AMR guidance regularly. Configure Barie to re-run the retrieval quarterly and flag changes in the Notion document. When the WHO publishes its post-2025 action plan or the CDC updates its Core Elements for the next five-year CARB cycle, the comparison updates automatically and a Slack alert goes to the relevant team. The comparison stays current without a new manual research session.

What you get

A structured comparison of WHO and CDC antimicrobial resistance guidance covering priority pathogen classification, antibiotic categorisation frameworks, stewardship programme requirements, and implementation timeline progress. Every claim linked to the primary WHO or CDC document that produced it. The 2024 WHO Bacterial Priority Pathogens List update, the 2023 CDC Core Elements revision, and the current CARB National Action Plan progress data — all present because they were retrieved from live official sources at query time, not from training data that predates their publication.

The Verdict

The WHO revised its Bacterial Priority Pathogens List in 2024. The CDC revised its Core Elements guidance in 2023. The WHO AMR Global Action Plan ends in 2025 and a successor framework is being drafted. Any comparison built from training data is describing guidance that has since been updated, in some cases materially. Barie Deep Research retrieves from WHO.int and CDC.gov at query time. Barie Web Research catches the amendments that postdate the indexed documents. The comparison reflects what both organisations are actually recommending today. For anyone working in AMR policy, research, or clinical practice, that is the only comparison that is fit for purpose.

Barie features used in this task

Next steps

→ Barie Deep Research — live retrieval from medical and regulatory databases

→ Prompt Library — medical guidelines and public health research templates

→ Wall of Love — what research and policy teams are building with Barie